These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 6151002)
41. Cross-regulation between G-protein-mediated pathways. Activation of the inhibitory pathway of adenylylcylclase increases the expression of beta 2-adrenergic receptors. Hadcock JR; Port JD; Malbon CC J Biol Chem; 1991 Jun; 266(18):11915-22. PubMed ID: 1646818 [TBL] [Abstract][Full Text] [Related]
42. Myocardial adenosine A1-receptor sensitivity during juvenile and adult stages of maturation. Sawmiller DR; Fenton RA; Dobson JG Am J Physiol; 1998 Feb; 274(2):H627-35. PubMed ID: 9486267 [TBL] [Abstract][Full Text] [Related]
43. Purification and characterization of (-)[125I]hydroxyphenylisopropyladenosine, an adenosine R-site agonist radioligand and theoretical analysis of mixed stereoisomer radioligand binding. Linden J Mol Pharmacol; 1984 Nov; 26(3):414-23. PubMed ID: 6092894 [TBL] [Abstract][Full Text] [Related]
44. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes. Wallace AV; Heyworth CM; Houslay MD Biochem J; 1984 Aug; 222(1):177-82. PubMed ID: 6089755 [TBL] [Abstract][Full Text] [Related]
45. Interaction of beta-adrenergic receptors with the inhibitory guanine nucleotide-binding protein of adenylate cyclase in membranes prepared from cyc- S49 lymphoma cells. Abramson SN; Martin MW; Hughes AR; Harden TK; Neve KA; Barrett DA; Molinoff PB Biochem Pharmacol; 1988 Nov; 37(22):4289-97. PubMed ID: 2848525 [TBL] [Abstract][Full Text] [Related]
46. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex. Alexander SP; Curtis AR; Kendall DA; Hill SJ Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308 [TBL] [Abstract][Full Text] [Related]
47. In situ analysis of adenylate cyclase activity in permeabilized rat adipocytes: sensitivity to GTP, isoproterenol, and N6-(phenylisopropyl)adenosine. Mooney RA; McDonald JM Int J Biochem; 1986; 18(8):713-8. PubMed ID: 3743877 [TBL] [Abstract][Full Text] [Related]
48. Autonomic interactions in the aging heart: age-associated decrease in muscarinic cholinergic receptor mediated inhibition of beta-adrenergic activation of adenylate cyclase. Narayanan N; Tucker L Mech Ageing Dev; 1986 May; 34(3):249-59. PubMed ID: 3014235 [TBL] [Abstract][Full Text] [Related]
49. Pharmacological characteristics of adenosine-induced inhibition of dog ventricular contractility: dependence on the pre-existing level of beta-adrenoceptor activation. Endoh M; Kushida H; Norota I; Takanashi M Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):70-8. PubMed ID: 1685559 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations. Ebersolt C; Premont J; Prochiantz A; Perez M; Bockaert J Brain Res; 1983 May; 267(1):123-9. PubMed ID: 6305455 [TBL] [Abstract][Full Text] [Related]
51. Rat adipose tissue adenosine sensitivity and adenosine content after subcutaneous administration of N6-(phenylisopropyl)adenosine. Stoneham S Acta Endocrinol (Copenh); 1989 Mar; 120(3):351-6. PubMed ID: 2929238 [TBL] [Abstract][Full Text] [Related]
52. Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels. Schütz W; Steurer G; Tuisl E Eur J Pharmacol; 1982 Nov; 85(2):177-84. PubMed ID: 6295779 [TBL] [Abstract][Full Text] [Related]
54. Guanine nucleotide and cation regulation of radioligand binding to Ri adenosine receptors of rat fat cells. Ukena D; Poeschla E; Schwabe U Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(3):241-7. PubMed ID: 6089005 [TBL] [Abstract][Full Text] [Related]
55. Dissociation between adenosine receptors and adenylate cyclase in the smooth muscle of guinea pig myometrium. Smith MA; Silverstein JL; Westfall DP; Buxton IL Cell Signal; 1989; 1(4):357-65. PubMed ID: 2642029 [TBL] [Abstract][Full Text] [Related]
56. Evidence against a regulation of Na+/K(+)-ATPase by Gi proteins. Failure to detect an influence of G proteins on Na+/Ca(2+)-exchange in cardiac sarcolemmal membranes. Mura RA; Zeifang F; Piacentini L; Kübler W; Rauch B; Niroomand F Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):505-12. PubMed ID: 8740143 [TBL] [Abstract][Full Text] [Related]
57. Adenosine receptors linked to adenylate cyclase activity in human neuroblastoma cells: modulation during cell differentiation. Abbracchio MP; Cattabeni F; Clementi F; Sher E Neuroscience; 1989; 30(3):819-25. PubMed ID: 2771050 [TBL] [Abstract][Full Text] [Related]
58. The interaction of adenosine analogues with cAMP-generating and cAMP-independent positive inotropic agents in rabbit left atrium. McKinley JB; Dahlman D; MacLeod KM Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):605-12. PubMed ID: 1965330 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of thyrotropin-stimulated adenosine 3',5'-monophosphate formation in rat thyroid cells by an adenosine analog. Evidence that the inhibition is mediated by the putative inhibitory guanine nucleotide regulatory protein. Berman MI; Thomas CG; Nayfeh SN J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(2):99-111. PubMed ID: 3016048 [TBL] [Abstract][Full Text] [Related]
60. Modulation of cardiac cyclic AMP metabolism by adenosine receptor agonists and antagonists. Ma H; Green RD Mol Pharmacol; 1992 Nov; 42(5):831-7. PubMed ID: 1331765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]